Structured evidence table for Sesame Seed Supplementation Blood Pressure Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Sesame Seed Supplementation Blood Pressure Randomized Trial | 1 2 3 4 Polycystic ovary syndrome (PCOS) is among the most frequent endocrine disorders in women of reproductive age and is strongly associated with multiple cardiometabolic disturbances. | 4 | Muacevic Alexander (2026) | Role of Functional Foods and Nutraceutical Compounds in Alleviating Polycystic Ovary Syndrome: A Narrative Review |
| Sesame Seed Supplementation Blood Pressure Randomized Trial | While these approaches can reduce symptoms, they mostly do not address the underlying endocrine or metabolic disturbances and may be associated with adverse effects, including gastrointestinal discomfort, weight gain, and fatigue [,]. | 4 | Muacevic Alexander (2026) | Role of Functional Foods and Nutraceutical Compounds in Alleviating Polycystic Ovary Syndrome: A Narrative Review |
| Sesame Seed Supplementation Blood Pressure Randomized Trial | Increasing evidence also points to the benefits of curcumin, a polyphenolic compound from turmeric, which down-regulates inflammatory mediators and oxidative stress, thereby improving insulin action []. | 4 | Muacevic Alexander (2026) | Role of Functional Foods and Nutraceutical Compounds in Alleviating Polycystic Ovary Syndrome: A Narrative Review |
| Sesame Seed Supplementation Blood Pressure Randomized Trial | Globally, the condition affects roughly 4-20% of women, underscoring its significance as a public-health concern [,]. | 4 | Muacevic Alexander (2026) | Role of Functional Foods and Nutraceutical Compounds in Alleviating Polycystic Ovary Syndrome: A Narrative Review |
| Sesame Seed Supplementation Blood Pressure Randomized Trial | ) supplementation may offer beneficial effects in modulating various cardiometabolic risk factors, although findings from clinical trials have been inconsistent. | 4 | Kuo WH (2026) | Integrative Evidence on Sesame Supplementation for Cardiometabolic Risk Factors Relevant to Retinopathy. |
| Sesame Seed Supplementation Blood Pressure Randomized Trial | Sesame supplementation significantly reduced both systolic and diastolic blood pressure. | 4 | Kuo WH (2026) | Integrative Evidence on Sesame Supplementation for Cardiometabolic Risk Factors Relevant to Retinopathy. |
| Sesame Seed Supplementation Blood Pressure Randomized Trial | Further-more, sesame intake was associated with a significant reduction in liver enzyme levels, particularly alanine aminotransferase (ALT). | 4 | Kuo WH (2026) | Integrative Evidence on Sesame Supplementation for Cardiometabolic Risk Factors Relevant to Retinopathy. |
| Sesame Seed Supplementation Blood Pressure Randomized Trial | Background Cardiometabolic disorders, such as diabetes, hypertension, dyslipidemia, retinopathy, and non-alcoholic fatty liver disease, present significant health challenges globally. | 4 | Kuo WH (2026) | Integrative Evidence on Sesame Supplementation for Cardiometabolic Risk Factors Relevant to Retinopathy. |
Source documents